Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Akzo Nobel reports new agents for dysentery

April 20, 1999

Inhibitex signs research agreement with BioResearch Ireland

April 16, 1999

Schering-Plough investigators discover water-soluble salt of antifungal azole

April 15, 1999

Broad-spectrum antifungal agents in development at Merck

April 13, 1999

Genome Pharmaceuticals and Evotec BioSystems enter drug discovery alliance

April 12, 1999

SBIR grant to Phytera for antibacterial drug discovery technology

April 12, 1999

Liposomal amphotericin B effective for empirical antifungal therapy

April 12, 1999

Anti-CMV activity of BDCRB evaluated in newly designed preclinical model

April 9, 1999

RPR-CMV-423: a promising candidate for treatment of human CMV infection

April 9, 1999

Versicor and Pharmacia & Upjohn join forces for development of new oxazolidinones

April 9, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...